According to a recent industry report by Fact.MR, the global biologics contract manufacturing market (生物製剤受託製造市場) is projected to reach a size of US$ 21.19 billion in 2024. The demand for biologics contract manufacturing worldwide is anticipated to grow at a substantial 9.4% compound annual growth rate (CAGR), reaching a market value of US$ 51.81 billion by 2034.

The Biologics Contract Manufacturing Market is a rapidly evolving sector within the pharmaceutical industry, driven by the increasing demand for biologics, which are complex molecules derived from living organisms. These molecules are used in the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases, among others. Biologics are typically more complex to manufacture than traditional small molecule drugs, requiring specialized facilities and expertise.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9572

Market Dynamics:

The growth of the Biologics Contract Manufacturing Market is primarily driven by the increasing adoption of biologics in the pharmaceutical industry. Biologics offer several advantages over traditional small molecule drugs, including higher specificity and lower toxicity, leading to better patient outcomes. Additionally, the expiration of patents on many biologics has led to the development of biosimilars, which are similar versions of biologics that offer cost savings to patients and healthcare providers.

Market Future Outlook:

The future outlook for the Biologics Contract Manufacturing Market (marché de la fabrication sous contrat de produits biologiques) is promising, with continued growth expected in the coming years. Factors such as the increasing prevalence of chronic diseases, the aging population, and the growing acceptance of biologics in the medical community are expected to drive market growth. Additionally, advancements in bioprocessing technologies and the development of novel biologics are expected to further fuel market expansion.

Market Insights:

The Biologics Contract Manufacturing Market (생물학적 제제 계약 제조 시장) is characterized by a high degree of competition, with a large number of contract manufacturing organizations (CMOs) offering services to pharmaceutical companies. Key market trends include the increasing outsourcing of biologics manufacturing by pharmaceutical companies, the growing trend towards personalized medicine, and the increasing use of single-use technologies in bioprocessing.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=9572

Key Players:

  • Lonza Group AG
  • BioXcellence
  • Samsung Biologics
  • AbbVie CM
  • Fujifilm Diosynth Biotechnologies
  • AGC Biologics
  • Patheon N.V.
  • Ajinomoto Bio-Pharma
  • Emergent BioSolutions Inc.
  • Avid Bioservices, Inc.
  • Rentschler Biotechnologies GmbH
  • KBI Biopharma
  • Merck KGaA
  • Novasep
  • Therapure Biopharma Inc.
  • Abzena Plc.
  • ProBioGen AG

Competitive Landscape:

Leading companies in the market are emphasizing their global distribution networks to drive revenue growth. They are also investing in supply chain management, new developments, and product quality.

For example, Abzena Limited collaborated with BiVictriX Therapeutics Plc. in November 2021 for the manufacturing of BiVictriX’s antibody-drug conjugates (ADCs).

Segmentation of Biologics Contract Manufacturing Market Research

  • By Product:
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Insulin
    • Vaccines
    • Interferons
    • Growth Factors
    • Others
  • By Platform:
    • Mammalian
    • Microbial
  • By Therapeutic Area:
    • Oncology
    • Metabolic Diseases
    • Autoimmune Diseases
    • Ophthalmology
    • Infectious Diseases
    • Cardiovascular Diseases
    • Neurology
    • Respiratory Disorders
    • Others
  • By Application:
    • Commercial
    • Clinical
  • By Region:
    • North America
    • Europe
    • East Asia
    • Latin America
    • Middle East & Africa
    • South Asia & Oceania

Explore More Related Studies Published by Fact.MR Research:

Genu Recurvatum Market (Marché du genou plié): https://www.factmr.com/report/genu-recurvatum-market

Hematocrit Test Market (헤마토크릿 테스트 시장): https://www.factmr.com/report/hematocrit-test-market

Metagenomic Sequencing Market (メタゲノムシーケンシング市場): https://www.factmr.com/report/metagenomic-sequencing-market

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com